Abstract:Purpose
To determine the safety and efficacy of adding topical bromfenac 0.09% in the treatment of diabetic macular edema.
Methods
Seventy patients (70 eyes) with centre involved diabetic macular edema (DME) with macular thickness (300-500um) were included. Patients were divided randomly into two groups; 35 eyes in each group. Both groups were treated with intravitreal ranibizumab monthly for three consecutive months. Bromfenac 0.09% eye drops twice daily was added to treatment of study group for six months fr… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.